The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes.EBI
University of California Santa Cruz
A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.EBI
University of California Santa Cruz
Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases.EBI
University of California Santa Cruz
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.EBI
University of California Santa Cruz
Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity.EBI
University of California Santa Cruz
Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.EBI
University of California Santa Cruz
Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.EBI
University of California Santa Cruz
Understanding and Improving the Membrane Permeability of VH032-Based PROTACs.EBI
University of California Santa Cruz
Discovery of anabaenopeptin 679 from freshwater algal bloom material: Insights into the structure-activity relationship of anabaenopeptin protease inhibitors.EBI
University of California Santa Cruz
Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.EBI
University of California Santa Cruz
Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog.BDB
Mayo Clinic